Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Nov 30, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, delivering a long-term and efficient method for managing intraocular pressure (IOP). In contrast to traditional eye drops that need to be applied every day, iDose® TR is a tiny, implantable device crafted to provide a controlled dispensation of treatment directly into the eye over an prolonged period. This innovative approach reduces the burden of constant dosing, greatly enhancing patient adherence and overall treatment outcomes.

At Eye Center South, we are honored to introduce iDose® TR as part of our all-encompassing glaucoma care. The device is placed during a gentle procedure, ensuring patient comfort and convenience. Once in place, it provides a steady flow of treatment, working to stabilize intraocular pressure and safeguarding your eyesight. Patients who find challenges in the challenges of daily eye drop regimens can experience significant advantages from this state-of-the-art treatment.



Visit for more info At Eye Center South